Friday May 9, 2025
HE
NEWSLETTER
www.israelhayom.com
  • Home
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
  • In Memoriam
www.israelhayom.com
  • Home
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
  • In Memoriam
www.israelhayom.com
Home Special Coverage Coronavirus Outbreak

A bat from the past? Scientists identify new Covid-like virus

Discovery at Wuhan facility shows virus uses similar cell entry mechanism as COVID-19.

by  Adi Nirman
Published on  02-23-2025 13:00
Last modified: 02-24-2025 10:31
A bat from the past? Scientists identify new Covid-like virusThomas Peter/Reuters

Security personnel keep watch outside Wuhan Institute of Virology during the visit by the World Health Organization (WHO) team tasked with investigating the origins of the coronavirus disease (COVID-19), in Wuhan, Hubei province, China February 3, 2021 | File photo: Thomas Peter/Reuters

Share on FacebookShare on Twitter

Chinese researchers have identified a new coronavirus in bats that enters human cells through the same pathway as SARS-CoV-2, according to Bloomberg. The discovery at the Wuhan Institute of Virology sparked movement in vaccine company stocks, despite no human infections being reported.

The research, published in the scientific journal Cell, revealed that the newly discovered bat virus shares key characteristics with the virus responsible for the COVID-19 pandemic, particularly in how it infiltrates cells.

Vaccine manufacturers saw their shares climb following the news. Moderna's stock rose up to 6.6%, while Novavax experienced an increase of up to 7.8%. BioNTech's American depositary receipts gained as much as 5.1%, and Pfizer shares increased up to 2.6%, according to Bloomberg.

Virologist Shi Zhengli (L) works in a lab of Wuhan Institute of Virology (WIV) in Wuhan, Hubei province, China, February 23, 2017 (re-issued 21 February 2025). Photo credit: Shepherd Hou/EPA/CHINA OUT EPA

The Wuhan facility, which specializes in bat coronavirus research, has been at the center of discussions about the pandemic's origins. The US terminated funding to the lab in 2023, ending support that had been channeled through the US-based EcoHealth Alliance.

Scientists found that the virus binds to a protein commonly present in humans and other mammals. The pathogen shows a close relation to the coronavirus family responsible for Middle East respiratory syndrome (MERS), Bloomberg reported.

MERS has infected approximately 2,600 people globally between 2012 and May 2024, with a mortality rate of about 36%. The World Health Organization reported that Saudi Arabia recorded the majority of these cases.

Tags: ChinaCOVID-19

Related Posts

Israel reinstates PCR tests at Ben-Gurion AirportYossi Zeliger

Israel reinstates PCR tests at Ben-Gurion Airport

by Shimon Yaish

Travelers returning from abroad can be tested for COVID at the government's expense. Testing is voluntary, for now.

Israel launches COVID vaccination campaign for children 5 and youngerGetty Images

Israel launches COVID vaccination campaign for children 5 and younger

by Maytal Yasur Beit-Or

Parents inoculating young children will be able to choose between Moderna and Pfizer shots. Healthcare providers stress the importance of...

Researchers discover Israeli coronavirus variant, but risk lowGetty Images / fotomay

Israeli startup develops drug platform to combat future COVID variants

by i24NEWS and ILH Staff

Platform speedily generates anti-viral drugs that target proteins common to all viruses. It could potentially also be used to also...

Menu

Analysis 

Archaeology

Blogpost

Business & Finance

Culture

Exclusive

Explainer

Environment

 

Features

Health

In Brief

Jewish World

Judea and Samaria

Lifestyle

Cyber & Internet

Sports

 

Diplomacy 

Iran & The Gulf

Gaza Strip

Politics

Shopping

Terms of use

Privacy Policy

Submissions

Contact Us

About Us

The first issue of Israel Hayom appeared on July 30, 2007. Israel Hayom was founded on the belief that the Israeli public deserves better, more balanced and more accurate journalism. Journalism that speaks, not shouts. Journalism of a different kind. And free of charge.

All rights reserved to Israel Hayom

Hosted by sPD.co.il

  • Home
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
    • Sports
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
    • Environment & Wildlife
    • Health & Wellness
  • In Memoriam
  • Subscribe to Newsletter
  • Submit your opinion
  • Terms and conditions

All rights reserved to Israel Hayom

Hosted by sPD.co.il

Newsletter

[contact-form-7 id=”508379″ html_id=”isrh_form_Newsletter_en” title=”newsletter_subscribe”]

  • Home
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
    • Sports
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
    • Environment & Wildlife
    • Health & Wellness
  • In Memoriam
  • Subscribe to Newsletter
  • Submit your opinion
  • Terms and conditions

All rights reserved to Israel Hayom

Hosted by sPD.co.il